Beam Therapeutics Inc. (BEAM)
USD 15.18
(-7.78%)
USD 15.18
(-7.78%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -262.72 Million USD | -388.68% |
| 2022 | -53.76 Million USD | 93.47% |
| 2021 | -823.29 Million USD | -1229.21% |
| 2020 | -61.93 Million USD | -429.53% |
| 2019 | -11.69 Million USD | 92.01% |
| 2018 | -146.44 Million USD | -16335.8% |
| 2017 | -891 Thousand USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -127.52 Million USD | -6.51% |
| 2024 Q3 | -68.13 Million USD | 46.57% |
| 2024 Q1 | -119.72 Million USD | 54.43% |
| 2023 Q2 | -50.2 Million USD | 31.53% |
| 2023 FY | -262.72 Million USD | -388.68% |
| 2023 Q4 | -262.72 Million USD | -7523.62% |
| 2023 Q3 | 3.53 Million USD | 107.05% |
| 2023 Q1 | -73.31 Million USD | -36.37% |
| 2022 Q3 | -919.65 Million USD | 7.35% |
| 2022 Q2 | -992.61 Million USD | -555.5% |
| 2022 Q1 | -151.42 Million USD | 81.61% |
| 2022 FY | -53.76 Million USD | 93.47% |
| 2022 Q4 | -53.76 Million USD | 94.15% |
| 2021 Q1 | 32.46 Million USD | 152.42% |
| 2021 Q3 | -472.41 Million USD | -523.81% |
| 2021 Q2 | -75.73 Million USD | -333.24% |
| 2021 FY | -823.29 Million USD | -1229.21% |
| 2021 Q4 | -823.29 Million USD | -74.27% |
| 2020 FY | -61.93 Million USD | -429.53% |
| 2020 Q4 | -61.93 Million USD | 64.42% |
| 2020 Q3 | -174.07 Million USD | -81.89% |
| 2020 Q2 | -95.7 Million USD | 1.63% |
| 2020 Q1 | -97.29 Million USD | -731.77% |
| 2019 FY | -11.69 Million USD | 92.01% |
| 2019 Q3 | -14.36 Million USD | 2.64% |
| 2019 Q2 | -14.75 Million USD | -110.08% |
| 2019 Q1 | 146.44 Million USD | 200.0% |
| 2019 Q4 | -11.69 Million USD | 18.59% |
| 2018 Q4 | -146.44 Million USD | 0.0% |
| 2018 FY | -146.44 Million USD | -16335.8% |
| 2018 Q1 | 1.9 Million USD | 0.0% |
| 2017 FY | -891 Thousand USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -369.65% |
| Alkermes plc | -166.73 Million USD | -57.565% |
| Agenus Inc. | 274.13 Million USD | 195.836% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 114.05% |
| Aptorum Group Limited | 1.35 Million USD | 19459.845% |
| Ardelyx, Inc. | 34.51 Million USD | 861.248% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 6238.364% |
| Bicycle Therapeutics plc | -481.46 Million USD | 45.433% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 826.494% |
| ChromaDex Corporation | -24.04 Million USD | -992.49% |
| Chimerix, Inc. | -25.51 Million USD | -929.596% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3870.366% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -1009.608% |
| CRISPR Therapeutics AG | -150.84 Million USD | -74.167% |
| Precision BioSciences, Inc. | -85.41 Million USD | -207.601% |
| Dyadic International, Inc. | -6.37 Million USD | -4019.127% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1548.917% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3527.554% |
| Lantern Pharma Inc. | -21.7 Million USD | -1110.518% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -137.678% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2975.226% |
| Incyte Corporation | -3.17 Billion USD | 91.726% |
| IO Biotech, Inc. | -140.69 Million USD | -86.726% |
| Jaguar Health, Inc. | 29.39 Million USD | 993.886% |
| Novavax, Inc. | -298.29 Million USD | 11.925% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 5022.653% |
| Opthea Limited | 28.15 Million USD | 1033.046% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1464.846% |
| ContextLogic Inc. | -232 Million USD | -13.242% |
| MiMedx Group, Inc. | -33.9 Million USD | -674.968% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2676.969% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -11238.754% |
| NextCure, Inc. | -6.47 Million USD | -3956.23% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -420.231% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -4018.545% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 2259.962% |
| Vaxcyte, Inc. | -368.22 Million USD | 28.652% |
| PDS Biotechnology Corporation | -32.7 Million USD | -703.213% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1620.558% |
| Pharming Group N.V. | 109.8 Million USD | 339.265% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1410.244% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -49.93% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1318.596% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1318.596% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -3600.31% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -4383.311% |
| Acelyrin, Inc. | -216.9 Million USD | -21.124% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -4582.879% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -15139.095% |
| Summit Therapeutics Inc. | 34.67 Million USD | 857.692% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3761.855% |
| Senti Biosciences, Inc. | 1.74 Million USD | 15198.966% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -42.314% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -239.211% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -4233.916% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 263430.293% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 41934.713% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -124.46% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -56.166% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 336.964% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -3358.689% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -103.481% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3910.548% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | -8.4% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1400.429% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 17.045% |
| MEI Pharma, Inc. | -3.7 Million USD | -6991.012% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 2199.928% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 262.433% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 1045.281% |
| Fortress Biotech, Inc. | 7.66 Million USD | 3527.554% |
| Precigen, Inc. | -481 Thousand USD | -54519.958% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1965.791% |
| AlloVir, Inc. | -62.69 Million USD | -319.068% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -372.403% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 526.04% |
| ImmuCell Corporation | 10.99 Million USD | 2490.433% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -70.437% |
| Onconetix, Inc. | 5.33 Million USD | 5027.79% |
| PureTech Health plc | -167.19 Million USD | -57.133% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -762.515% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1274.213% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -5251.844% |
| Seer, Inc. | -4.24 Million USD | -6096.274% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -992.99% |
| Innoviva, Inc. | 255.56 Million USD | 202.801% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -370.289% |
| ESSA Pharma Inc. | -33.62 Million USD | -681.409% |
| GlycoMimetics, Inc. | -40.98 Million USD | -541.029% |
| GT Biopharma, Inc. | -1.02 Million USD | -25631.832% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -287.593% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 528.885% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -95.946% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1796.088% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -809.954% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -348642.931% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -751.28% |
| Aptose Biosciences Inc. | -8.19 Million USD | -3105.938% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -8296.308% |
| Soligenix, Inc. | -4.95 Million USD | -5205.803% |
| Century Therapeutics, Inc. | 847 Thousand USD | 31117.946% |
| Kura Oncology, Inc. | -20.11 Million USD | -1205.905% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -541.944% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -3028.388% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 14521.843% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -8117.767% |
| Autolus Therapeutics plc | -186.59 Million USD | -40.795% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -432.861% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 4.74% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 866.669% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 259.838% |
| GRI Bio, Inc. | -1.79 Million USD | -14544.482% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2824.643% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -689.975% |
| IGM Biosciences, Inc. | -72.6 Million USD | -261.846% |
| INmune Bio, Inc. | -25.41 Million USD | -933.891% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 274.045% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -418.609% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1516.813% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -9006.715% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 791.101% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -537.907% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 923.967% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 169.512% |
| Verastem, Inc. | -37.27 Million USD | -604.764% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2795.646% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -406.579% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1635.857% |
| Histogen Inc. | -7.48 Million USD | -3409.042% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -1115.922% |
| Surrozen, Inc. | -32.66 Million USD | -704.317% |
| Organovo Holdings, Inc. | -1.5 Million USD | -17333.444% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6150.095% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1485.649% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 10142.89% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 6421.511% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -3034.677% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -504.765% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1702.322% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 17.067% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -36285.065% |
| Apollomics, Inc. | -27.39 Million USD | -859.014% |
| Amarin Corporation plc | -191.04 Million USD | -37.522% |
| Mesoblast Limited | 55.96 Million USD | 569.457% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1701.44% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -938.755% |
| Synaptogenix, Inc. | -28.66 Million USD | -816.637% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -27968.59% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 639.116% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -30375.044% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -3515.732% |
| Exelixis, Inc. | -73.05 Million USD | -259.647% |
| Better Therapeutics, Inc. | -860 Thousand USD | -30449.07% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -994.082% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | -8.846% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 35792.723% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -3432.095% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 21050.718% |
| Gritstone bio, Inc. | 39.49 Million USD | 765.287% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -212.389% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -9881.308% |
| Avid Bioservices, Inc. | 169.72 Million USD | 254.79% |
| Insmed Incorporated | 721.62 Million USD | 136.407% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2773.945% |
| MediWound Ltd. | -5.32 Million USD | -4836.528% |
| OmniAb, Inc. | 9.2 Million USD | 2954.743% |
| Alector, Inc. | -35.63 Million USD | -637.217% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 405.594% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -5231.209% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 2084.455% |
| Zai Lab Limited | -775 Million USD | 66.1% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 177.145% |
| Aura Biosciences, Inc. | -21.52 Million USD | -1120.544% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -218.528% |
| Immunic, Inc. | -45.34 Million USD | -479.449% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -35.974% |
| Veracyte, Inc. | -203.82 Million USD | -28.896% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 141.16% |
| FibroGen, Inc. | 56.76 Million USD | 562.808% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3050.275% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -9193.045% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -12589.751% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 105.723% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -7763.574% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -58.301% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1570.843% |
| Galecto, Inc. | -21.21 Million USD | -1138.32% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -1004.57% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 116.74% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -973.562% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -2183.149% |
| XBiotech Inc. | -200.02 Million USD | -31.346% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -212.389% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 5902.164% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -645.036% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -240.234% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 4716.447% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -54.166% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -184.411% |
| Vaxxinity, Inc. | 10.13 Million USD | 2692.992% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 135.683% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -2339.942% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -298.329% |
| NexImmune, Inc. | -3.13 Million USD | -8283.916% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -7509.235% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1638.562% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -869.454% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2826.921% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -210794.642% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -547.545% |
| Ainos, Inc. | 4.07 Million USD | 6542.537% |
| Pluri Inc. | 22.82 Million USD | 1250.826% |
| Prothena Corporation plc | -608.34 Million USD | 56.814% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -121.228% |
| Celularity Inc. | 65.19 Million USD | 503.01% |
| Rallybio Corporation | -24.1 Million USD | -990.042% |
| Cue Biopharma, Inc. | -33.81 Million USD | -676.847% |
| MeiraGTx Holdings plc | -40.3 Million USD | -551.883% |
| Omeros Corporation | 331.17 Million USD | 179.33% |
| Humacyte, Inc. | -22.48 Million USD | -1068.38% |
| Immunocore Holdings plc | -358.59 Million USD | 26.736% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -969.062% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -750.205% |
| Blueprint Medicines Corporation | 702.83 Million USD | 137.38% |
| CalciMedica, Inc. | -5.53 Million USD | -4650.85% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -39.582% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2472.175% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -556.198% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -690.07% |
| Pulmatrix, Inc. | -10.41 Million USD | -2422.05% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -4295.55% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -588.8% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -135.832% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -338.279% |
| Cytokinetics, Incorporated | 642.37 Million USD | 140.899% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -4411.798% |
| Nutriband Inc. | -251.65 Thousand USD | -104296.858% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -670.017% |
| Vor Biopharma Inc. | 4.3 Million USD | 6209.814% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 95.647% |
| Evogene Ltd. | -19.63 Million USD | -1238.097% |
| ProKidney Corp. | -56.23 Million USD | -367.178% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -439.781% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2744.178% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 119.263% |
| CorMedix Inc. | -43.05 Million USD | -510.236% |
| BioLineRx Ltd. | 7.33 Million USD | 3681.27% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -856.57% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 669.315% |
| Atai Life Sciences N.V. | -28.55 Million USD | -819.959% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 11878.462% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -1051.481% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1581.376% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -249.951% |
| MediciNova, Inc. | -50.78 Million USD | -417.337% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -233.382% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1167812.87% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3971.575% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -31.479% |
| Biomea Fusion, Inc. | -166.57 Million USD | -57.725% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -46.793% |
| Mereo BioPharma Group plc | -51.46 Million USD | -410.447% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -177.004% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 10.565% |
| Absci Corporation | -72.59 Million USD | -261.886% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5853.876% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | -12.065% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -178.866% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -174.538% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -572.388% |
| Allakos Inc. | -24.97 Million USD | -951.94% |
| Imunon, Inc. | -4.21 Million USD | -6134.723% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1682.133% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -94.034% |
| BioAtla, Inc. | -109.01 Million USD | -141.005% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 35792.723% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -27878.914% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 2295.571% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -1139.079% |
| XOMA Corporation | -29 Million USD | -805.938% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1486.486% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2813.953% |
| aTyr Pharma, Inc. | -7.44 Million USD | -3426.943% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -110.791% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -26.209% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -221.259% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -183.219% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -30478.083% |
| Akari Therapeutics, Plc | -3.84 Million USD | -6732.822% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 16288.528% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 119.026% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -22012.134% |
| UroGen Pharma Ltd. | 4.39 Million USD | 6083.193% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 331.512% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 365184.35% |
| Orgenesis Inc. | 21.78 Million USD | 1306.032% |
| Entera Bio Ltd. | -10.62 Million USD | -2371.747% |
| GH Research PLC | -78.07 Million USD | -236.491% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -1078.76% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -885.491% |
| Xencor, Inc. | 29.64 Million USD | 986.257% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -13237.415% |
| Replimune Group, Inc. | 1.41 Million USD | 18706.374% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -107173.752% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -107.822% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -22012.134% |
| Portage Biotech Inc. | -4.98 Million USD | -5174.483% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -1167812.87% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -297.329% |
| OncoCyte Corporation | -6.56 Million USD | -3903.078% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 29375.484% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -5666.958% |
| Purple Biotech Ltd. | -14.13 Million USD | -1758.268% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -1005.919% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3914.087% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1473.924% |
| HilleVax, Inc. | -165.48 Million USD | -58.759% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -10251.537% |
| Tharimmune, Inc. | -10.93 Million USD | -2302.502% |
| Genprex, Inc. | -6.73 Million USD | -3799.324% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 28.764% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -196.995% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -18652.463% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -7820.599% |
| OKYO Pharma Limited | -826.84 Thousand USD | -31673.917% |
| Savara Inc. | 153 Thousand USD | 171813.725% |
| Curis, Inc. | -23.88 Million USD | -999.853% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4993.574% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -33755.404% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -4131.991% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 22270.633% |
| BeiGene, Ltd. | -2.25 Billion USD | 88.339% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 2229.286% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 56.804% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -41.563% |
| Erasca, Inc. | -37.21 Million USD | -605.938% |
| bluebird bio, Inc. | 108.57 Million USD | 341.982% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -20299.365% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 169.366% |
| DBV Technologies S.A. | -126.98 Million USD | -106.891% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -20299.365% |
| Moderna, Inc. | -2.9 Billion USD | 90.962% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -2437.886% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -2317.391% |
| Molecular Templates, Inc. | 707 Thousand USD | 37260.113% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -737.468% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 175.798% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -220.151% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -186.408% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -714.087% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -664.26% |
| MacroGenics, Inc. | -66.98 Million USD | -292.21% |
| RenovoRx, Inc. | -1.17 Million USD | -22297.442% |
| Adicet Bio, Inc. | -138.78 Million USD | -89.299% |
| Prime Medicine, Inc. | -27.94 Million USD | -840.274% |
| Aditxt, Inc. | 18.12 Million USD | 1549.83% |
| Adagene Inc. | -87.62 Million USD | -199.817% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6207.203% |
| Quantum-Si incorporated | -118.55 Million USD | -121.6% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 829.682% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -3415.057% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -441.594% |
| SciSparc Ltd. | -2.06 Million USD | -12622.615% |
| Vericel Corporation | 1.27 Million USD | 20673.375% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2090.865% |
| Minerva Neurosciences, Inc. | 41 Million USD | 740.719% |
| Generation Bio Co. | 31.44 Million USD | 935.417% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -49.815% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -749.601% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 325.333% |
| Invivyd, Inc. | -198.47 Million USD | -32.37% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -191.04% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -10857.304% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -271.129% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3749.407% |
| 2seventy bio, Inc. | 181.71 Million USD | 244.579% |
| ADMA Biologics, Inc. | 90.06 Million USD | 391.699% |
| Clene Inc. | 3.34 Million USD | 7965.928% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2792.553% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -1121.338% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3971.575% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 23.655% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -910.482% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 247.874% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -6321.061% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 5352.339% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4943.617% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -101.622% |
| Evaxion Biotech A/S | 5.28 Million USD | 5069.354% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -133.39% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -100.134% |
| Trevena, Inc. | 2.25 Million USD | 11735.164% |
| Surrozen, Inc. | -32.66 Million USD | -704.317% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -410.041% |
| Cingulate Inc. | 3.08 Million USD | 8622.511% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -8845.25% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3755.517% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2727.635% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -231.205% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -99.862% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -148.926% |
| Clearmind Medicine Inc. | -3.94 Million USD | -6563.611% |
| Kronos Bio, Inc. | -36.05 Million USD | -628.69% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2892.241% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 18117.772% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -384.227% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1922.382% |
| ImmunityBio, Inc. | 618.22 Million USD | 142.496% |
| Korro Bio, Inc. | -132.94 Million USD | -97.62% |
| Kineta, Inc. | -4.54 Million USD | -5685.554% |
| BioVie Inc. | -17.73 Million USD | -1381.597% |
| Codexis, Inc. | -43.27 Million USD | -507.155% |
| Celularity Inc. | 65.19 Million USD | 503.01% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -8190.376% |
| Celcuity Inc. | 6.78 Million USD | 3972.951% |
| Virax Biolabs Group Limited | -3.36 Million USD | -7707.619% |
| Cibus, Inc. | -8.07 Million USD | -3152.315% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -6112.391% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 5848.84% |
| IN8bio, Inc. | -16.38 Million USD | -1503.039% |
| Kodiak Sciences Inc. | -103.87 Million USD | -152.921% |
| Annexon, Inc. | -193.75 Million USD | -35.595% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 729883.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1401.354% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -7378.565% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 124.92% |
| Eyenovia, Inc. | 1.25 Million USD | 20972.454% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 1076.48% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8001.203% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -690.213% |
| Arcellx, Inc. | -296.95 Million USD | 11.529% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1246.878% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -346.237% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -1167.535% |
| Moolec Science SA | 117.61 Thousand USD | 223472.67% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -584.19% |
| Geron Corporation | 14.76 Million USD | 1879.839% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -592.869% |
| Royalty Pharma plc | 5.65 Billion USD | 104.643% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -85.773% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3658.851% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -4798.917% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -86.684% |
| Humacyte, Inc. | -22.48 Million USD | -1068.38% |
| Structure Therapeutics Inc. | -124.33 Million USD | -111.295% |
| 89bio, Inc. | -289.05 Million USD | 9.109% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -940.813% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -14634.829% |
| Genelux Corporation | -6.89 Million USD | -3708.117% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -745.88% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 414.265% |
| Notable Labs, Ltd. | -9.77 Million USD | -2587.418% |
| Liquidia Corporation | -80.17 Million USD | -227.682% |
| Mustang Bio, Inc. | -3.73 Million USD | -6932.173% |
| Immunovant, Inc. | -635.22 Million USD | 58.641% |
| Quantum-Si incorporated | -118.55 Million USD | -121.6% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1395.798% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -6241.347% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 3372.979% |
| Acasti Pharma Inc. | -23 Million USD | -1042.021% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -7702.321% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1516.813% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -90.738% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -8330.407% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -1081.729% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1314.842% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -55.202% |
| PepGen Inc. | -60.67 Million USD | -333.034% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -1043.463% |
| United Therapeutics Corporation | -507.7 Million USD | 48.253% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1273.638% |
| Solid Biosciences Inc. | -47.75 Million USD | -450.203% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -30375.044% |
| Immuneering Corporation | -54.94 Million USD | -378.173% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -6150.095% |
| Silo Pharma, Inc. | -3.52 Million USD | -7354.57% |
| Belite Bio, Inc | -87.27 Million USD | -201.042% |
| XOMA Corporation | -29 Million USD | -805.938% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -271.617% |
| Bionomics Limited | 227 Million USD | 215.732% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -125.935% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10271.97% |
| uniQure N.V. | -102.95 Million USD | -155.191% |
| Cassava Sciences, Inc. | -121.13 Million USD | -116.882% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -6207.203% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 741.552% |
| Forte Biosciences, Inc. | -11.96 Million USD | -2096.489% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -8390.789% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 247950.943% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -8001.203% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 3050.275% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -3442.638% |
| Altimmune, Inc. | -134.48 Million USD | -95.351% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 232.644% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -10271.97% |
| Compugen Ltd. | -12.9 Million USD | -1935.973% |
| Peak Bio, Inc. | 10.34 Million USD | 2640.793% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -92734.629% |
| Benitec Biopharma Inc. | -50.58 Million USD | -419.398% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -151.799% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1437.348% |
| Zura Bio Limited | -99.8 Million USD | -163.233% |
| PolyPid Ltd. | 6.17 Million USD | 4358.055% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 454.455% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1437.348% |
| Instil Bio, Inc. | 75.35 Million USD | 448.632% |
| argenx SE | -2.02 Billion USD | 87.051% |
| Immunome, Inc. | -97.02 Million USD | -170.766% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -1067.913% |
| Verona Pharma plc | -220.44 Million USD | -19.179% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -266.199% |
| Shattuck Labs, Inc. | -121.42 Million USD | -116.367% |
| CervoMed Inc. | -7.79 Million USD | -3271.323% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -41.63% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -5907.821% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -99.425% |
| Moolec Science SA | 117.61 Thousand USD | 223472.67% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -11382.72% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1752.508% |
| AnaptysBio, Inc. | -18.15 Million USD | -1347.424% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1347.504% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -273.285% |
| NeurAxis, Inc. | 145.7 Thousand USD | 180417.09% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2439.049% |
| Lumos Pharma, Inc. | -28.49 Million USD | -822.058% |
| Achilles Therapeutics plc | -126.92 Million USD | -106.992% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -266.199% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -39965.576% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -1164.678% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 18117.772% |
| Nutriband Inc. | -251.65 Thousand USD | -104296.858% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1894.7% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -3431.21% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 177.226% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1206.897% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 41.287% |
| Palisade Bio, Inc. | -12.06 Million USD | -2077.916% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -87.243% |
| Neurogene Inc. | -131.95 Million USD | -99.1% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1304.263% |
| AEON Biopharma, Inc. | -4.88 Million USD | -5283.648% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 30.348% |
| Sesen Bio, Inc. | -112.55 Million USD | -133.421% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -163.09% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -11090.169% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -573.197% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -215.461% |
| Athira Pharma, Inc. | -88.99 Million USD | -195.197% |
| Vaccinex, Inc. | -1.28 Million USD | -20297.671% |
| HCW Biologics Inc. | 2.85 Million USD | 9296.773% |
| XOMA Corporation | -29 Million USD | -805.938% |
| Nektar Therapeutics | 210.24 Million USD | 224.963% |
| Arvinas, Inc. | -313.8 Million USD | 16.277% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 16288.528% |
| Merus N.V. | -192.88 Million USD | -36.207% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 537.979% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3686.711% |
| Rezolute, Inc. | -68.16 Million USD | -285.404% |
| Clene Inc. | 3.34 Million USD | 7965.928% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1892.28% |
| BeyondSpring Inc. | -13.75 Million USD | -1810.011% |
| Synlogic, Inc. | -6.68 Million USD | -3830.022% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 23267.725% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -3007.297% |
| Peak Bio, Inc. | 10.34 Million USD | 2640.793% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -218.76% |
| Krystal Biotech, Inc. | -350.23 Million USD | 24.987% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 311.659% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -55.46% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -8221.508% |
| MannKind Corporation | 143.89 Million USD | 282.574% |
| Ikena Oncology, Inc. | -109.15 Million USD | -140.685% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -3370.11% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -693.722% |
| Gossamer Bio, Inc. | 180.35 Million USD | 245.669% |
| CohBar, Inc. | -5.93 Million USD | -4329.842% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -783.159% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 5853.876% |
| Legend Biotech Corporation | -949.39 Million USD | 72.328% |
| Mural Oncology plc | -255.84 Million USD | -2.689% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 915.527% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -5477.202% |
| Disc Medicine, Inc. | -358.28 Million USD | 26.672% |
| Champions Oncology, Inc. | 4.81 Million USD | 5559.726% |
| REGENXBIO Inc. | 54.76 Million USD | 579.7% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -97599.948% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -73.96% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2815.244% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -225.622% |
| Vaxart, Inc. | -8.24 Million USD | -3087.987% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -423.56% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -106.598% |
| Cellectis S.A. | -43.85 Million USD | -499.07% |
| Longeveron Inc. | -2.9 Million USD | -8934.457% |
| Repare Therapeutics Inc. | -107.85 Million USD | -143.581% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 127.13% |
| Inozyme Pharma, Inc. | 12 Million USD | 2288.62% |
| Revolution Medicines, Inc. | -608.2 Million USD | 56.804% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -21259.512% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 0.903% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -75.064% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1579.057% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -35402.973% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.253% |
| Denali Therapeutics Inc. | -74.86 Million USD | -250.928% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -2090.865% |
| Veru Inc. | 4.77 Million USD | 5596.312% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -2236.137% |
| Cingulate Inc. | 3.08 Million USD | 8622.511% |
| Passage Bio, Inc. | 4.58 Million USD | 5830.033% |
| Context Therapeutics Inc. | -14.44 Million USD | -1718.167% |
| Exicure, Inc. | 5.84 Million USD | 4591.742% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | -14.041% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -563.942% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1774.348% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -346.647% |
| Nuvalent, Inc. | -335.38 Million USD | 21.666% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 15248.232% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -252.732% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2855.253% |
| OmniAb, Inc. | 9.2 Million USD | 2954.743% |
| Anew Medical, Inc. | 1.43 Million USD | 18440.553% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1703.748% |
| Lipocine Inc. | -4.75 Million USD | -5425.648% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -139.212% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1824.916% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -418.609% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 1155.448% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3808.972% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -299.11% |
| Ocugen, Inc. | -32.52 Million USD | -707.853% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -207.008% |
| Q32 Bio Inc. | -37.94 Million USD | -592.321% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -41734.713% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1841.917% |
| Equillium, Inc. | -22.39 Million USD | -1073.285% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -927.542% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -705.235% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -105872.612% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 296.0% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 8315.197% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 80090.622% |
| Dominari Holdings Inc. | 195 Thousand USD | 134829.231% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4888.162% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2846.305% |
| Bio-Techne Corporation | 267.74 Million USD | 198.123% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1520.84% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -122.469% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -3026.526% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1976.69% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | -7.181% |
| Nkarta, Inc. | 57.29 Million USD | 558.511% |
| BioCardia, Inc. | 212 Thousand USD | 124025.472% |
| Iterum Therapeutics plc | 13.43 Million USD | 2055.068% |